共 123 条
[31]
Wu YL(2009)Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance Clin Cancer Res 15 3484-7282
[32]
Zhou C(2009)Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivo Cancer Res 69 5091-e29
[33]
Hu CP(2005)Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp Cancer Res 65 7276-5537
[34]
Pao W(2013)Does T790M disappear? Successful gefitinib rechallenge after T790M disappearance in a patient with EGFR-mutant non-small cell lung cancer J Thorac Oncol 8 e27-2247
[35]
Miller VA(2011)Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling Sci Transl Med 3 9059-1528
[36]
Politi KA(2011)New strategies in overcoming acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in lung cancer Clin Cancer Res 17 5530-1146
[37]
Kobayashi S(2013)Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers Clin Cancer Res 19 2240-undefined
[38]
Boggon TJ(2012)Loss of activating EGFR mutant gene contributes to acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer cells PLoS One 7 e41017-undefined
[39]
Dayaram T(2013)Mechanisms of acquired resistance to EGFR-tyrosine kinase inhibitor in Korean patients with lung cancer BMC Cancer 13 606-undefined
[40]
Engelman JA(2010)Complex mutations in the epidermal growth factor receptor gene in non-small cell lung cancer J Thorac Oncol 5 1524-undefined